Search - tctmd.com

Displaying 101 - 120 of 1033

Sort: Relevancy | Date

Presentation TCT 2023

DAPT After PCI: Do We Need It at All?

Presenter: Fausto Feres

October 24, 2023

Presentation TCT 2023

DAPT Duration: Unsettled or Case Closed?

Presenter: Duk-Woo Park

October 24, 2023

Presentation TCT 2023

Standardizing The Language Around DAPT: An ARC Initiative

Presenter: Davide Capodanno

October 24, 2023

Presentation TCT 2023

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

Presenter: Roxana Mehran

October 24, 2023

Presentation TCT 2023

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Presenter: Dominick Angiolillo

October 24, 2023

Presentation TCT 2023

Clopidogrel Monotherapy Following 1-month DAPT versus Aspirin Monotherapy Following 12-month DAPT in Patients Receiving PCI; Final 5-year Result of STOPDAPT-2

Presenter: Hirotoshi Watanabe

October 23, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

Podcast TCTMD Talking Points

MASTER DAPT: Long-Term Results

September 13, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Yael L. Maxwell

September 05, 2023

News Conference News ESC 2023

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Todd Neale

August 26, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Todd Neale

June 20, 2023

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

L.A. McKeown

May 30, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Todd Neale

May 18, 2023

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

Advertisement

DAPT After PCI: Do We Need It at All?

DAPT Duration: Unsettled or Case Closed?

Standardizing The Language Around DAPT: An ARC Initiative

Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model

Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example

Clopidogrel Monotherapy Following 1-month DAPT versus Aspirin Monotherapy Following 12-month DAPT in Patients Receiving PCI; Final 5-year Result of STOPDAPT-2

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

MASTER DAPT: Long-Term Results

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

TCTMD’s Top 10 Most Popular Stories for February 2023

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content